DARU-Journal of Pharmaceutical Sciences

Papers
(The H4-Index of DARU-Journal of Pharmaceutical Sciences is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Multi-functionalization of reduced graphene oxide nanosheets for tumor theragnosis: Synthesis, characterization, enzyme assay, in-silico study, radiolabeling and in vivo targeting evaluation63
New psychoactive substances: a multidisciplinary review of challenges and their diverse character33
Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study25
Dispersive micro-solid phase extraction based on two MOFs as highly effective adsorbents for analysis of nilotinib in plasma and wastewater23
Effect of vitamins C and E on cancer survival; a systematic review22
Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer20
Lipid nanoparticles for gene therapy in ocular diseases19
Stearyl amine tailored spanlastics embedded within tetronic® nanogel for boosting the repurposed anticancer potential of mebendazole: formulation, in vitro profiling, cytotoxicity assessment, and in v19
Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population19
Evaluation of clinical and safety outcomes of generic tacrolimus (Suprotac $$\circledR$$) versus branded tacrolimus (Prograf $$\circledR$$) in de novo liver transplant patients: a randomized clinical 18
Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis17
Cleaning validation in pharmaceutical quality control laboratories: a structured protocol for contamination risk mitigation16
Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations16
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines14
0.036454916000366